Alexandria Real Estate Equities, Inc는 주당 5.3186의 연간 배당금을 지급하며, 수익률은 9.6482%입니다. 배당금은 분기별에 지급되며, 마지막 배당금 지급일은 Jun 30, 2026였습니다.
배당수익률
연간 배당금
배당금 지급일 전일
9.6482%
$5.3186
Jun 30, 2026
지급 빈도
지급 비율
분기별
34.22%
배당금 이력
배당금 지급일 전일
현금 금액
기록 일자
지급일
Jun 30, 2026
$0.72
Jun 30, 2026
Jul 15, 2026
Mar 31, 2026
$0.72
Mar 31, 2026
Apr 15, 2026
Dec 31, 2025
$0.72
Dec 31, 2025
Jan 15, 2026
Sep 30, 2025
$1.32
Sep 30, 2025
Oct 15, 2025
Jun 30, 2025
$1.32
Jun 30, 2025
Jul 15, 2025
Mar 31, 2025
$1.32
Mar 31, 2025
Apr 15, 2025
배당금 차트
ARE 배당금
ARE 배당금 성장률(년간 비교)
Follow-Up Questions
Alexandria Real Estate Equities, Inc의 현재 배당금과 연간 배당금은 얼마인가요?
Alexandria Real Estate Equities, Inc이 현재 지급하는 배당금은 $0.72입니다. Alexandria Real Estate Equities, Inc의 연간 배당금은 $5.3186입니다.
Alexandria Real Estate Equities, Inc의 배당 성향은 얼마인가요?
Alexandria Real Estate Equities, Inc의 배당 성향은 34.22%입니다.
ARE의 배당락일은 언제인가요?
Alexandria Real Estate Equities, Inc의 배당락일은 Jun 30, 2026입니다.
Alexandria Real Estate Equities, Inc은 얼마나 자주 배당금을 지급하나요?
분기별. Alexandria Real Estate Equities, Inc이 마지막으로 배당금을 지급한 날짜는 Jul 15, 2026입니다.
주요 통계
이전 종가
$48.48
시가
$48.7
일일 범위
$48.18 - $50.17
52주 범위
$39.41 - $88.24
거래량
1.4M
평균 거래량
2.1M
배당수익률
9.65%
EPS(TTM)
-6.22
시가총액
$8.6B
ARE란 무엇인가요?
Alexandria Real Estate Equities, Inc. engages in the provision of space for lease. The company is headquartered in Pasadena, California and currently employs 514 full-time employees. The firm is an owner, operator and developer of collaborative life science, agricultural technology (agtech), and advanced technology mega campuses in AAA innovation cluster locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle. The Company, through its venture capital platform, provides strategic capital to life science, agrifoodtech, climate innovation, and technology companies. Its tenants include multinational pharmaceutical companies; public and private biotechnology companies; life science product, service and medical device companies; digital health, technology, and agtech companies; academic and medical research institutions; United States government research agencies; non-profit organizations, and venture capital firms. The company has a Labspace asset base predominantly concentrated in markets with barriers to entry.